Australia markets close in 15 minutes

Cipla Limited (CIPLA.BO)

BSE - BSE Real-time price. Currency in INR
Add to watchlist
1,470.00+16.25 (+1.12%)
As of 10:12AM IST. Market open.

Cipla Limited

Cipla House
Peninsula Business Park Ganpatrao Kadam Marg Lower Parel
Mumbai 400013
India
91 22 2482 6000
https://www.cipla.com

Sector(s)Healthcare
IndustryDrug Manufacturers - General
Full-time employees32,323

Key executives

NameTitlePayExercisedYear born
Mr. Umang VohraMD, Global CEO & Executive Director174.9MN/A1971
Ms. Samina HamiedExecutive Vice-Chairperson92.5MN/A1976
Dr. Raju Sunil Mistry M.A., Ph.D.President & Global Chief People OfficerN/AN/A1965
Mr. Pradeep BhadauriaPresident & Chief Scientific OfficerN/AN/AN/A
Mr. Ashish AdukiaGlobal Chief Financial OfficerN/AN/AN/A
Mr. Dinesh Ramniranjan JainSenior VP & Head of Corporate FinanceN/AN/AN/A
Ms. Geena V. MalhotraGlobal Chief Technology OfficerN/AN/AN/A
Mr. Naveen BansalHead of Investor RelationsN/AN/AN/A
Mr. Rajendra Kumar ChopraCompliance Officer & Company Secretary15.3MN/AN/A
Ms. Heena KanalSenior Vice-President of Corporate CommunicationsN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Cipla Limited, together with its subsidiaries, manufactures, develops, and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New ventures segments. It also offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. In addition, the company provides respiratory products, including inhalers and nasal sprays, as well as other respiratory products consists of injectables and biosimilars. Further, it offers Easylax and Easylax L, a liquid paraffin for constipation. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.

Corporate governance

Cipla Limited’s ISS governance QualityScore as of 1 February 2024 is 3. The pillar scores are Audit: 3; Board: 2; Shareholder rights: 1; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.